|Articles|November 11, 2022
physIQ Launches Intrepid Partner Program
The Intrepid Partner Program aims to accelerate the optimization of patient safety and health measurements in both clinical research and post market clinical care.
Advertisement
physIQ announced the launch of its Intrepid™ Partner Program, designed to enable the life sciences solutions ecosystem to deliver real time patient insights powered by medical grade biosensor data streams in both clinical and remote patient settings.
Read more about the program
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
Designing Feasible Protocols with Real-World Data
4
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
